![Brad L. Stewart](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Brad L. Stewart
Keine laufenden Positionen mehr
Profil
Brad L.
Stewart served as Chairman, President & Chief Executive Officer at Cylex, Inc. from 2009 to 2013.
He also worked as a Director at Tech Council of Maryland, Inc. Mr. Stewart obtained his undergraduate degree from the University of Florida.
Ehemalige bekannte Positionen von Brad L. Stewart
Unternehmen | Position | Ende |
---|---|---|
Cylex, Inc.
![]() Cylex, Inc. Medical SpecialtiesHealth Technology Cylex is a privately held global life science company that is in the development and manufacture of in vitrodiagnostic products. ImmuKnow is the in vitro diagnostic utilized to detect cell-mediated immunity (CMI) in an immunosuppressed population and is increasingly being adopted at organ transplant centers throughout the United States and abroad. The Company's patented technology provides a platform allowing clinical researchers to simply and reproducibly measure CMI for the development of new diagnostics, biomarkers and companion assays. The company is based in Columbia, MD and was founded in 1992 | Vorsitzender | 18.11.2013 |
Tech Council of Maryland, Inc.
![]() Tech Council of Maryland, Inc. Miscellaneous Commercial ServicesCommercial Services Tech Council of Maryland, Inc. provides membership association services for technology and life science communities. The firm serves the advanced technology and biotechnology communities. The company was founded in 1986 and is headquartered in Rockville, MD. | Direktor/Vorstandsmitglied | - |
Ausbildung von Brad L. Stewart
University of Florida | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Cylex, Inc.
![]() Cylex, Inc. Medical SpecialtiesHealth Technology Cylex is a privately held global life science company that is in the development and manufacture of in vitrodiagnostic products. ImmuKnow is the in vitro diagnostic utilized to detect cell-mediated immunity (CMI) in an immunosuppressed population and is increasingly being adopted at organ transplant centers throughout the United States and abroad. The Company's patented technology provides a platform allowing clinical researchers to simply and reproducibly measure CMI for the development of new diagnostics, biomarkers and companion assays. The company is based in Columbia, MD and was founded in 1992 | Health Technology |
Tech Council of Maryland, Inc.
![]() Tech Council of Maryland, Inc. Miscellaneous Commercial ServicesCommercial Services Tech Council of Maryland, Inc. provides membership association services for technology and life science communities. The firm serves the advanced technology and biotechnology communities. The company was founded in 1986 and is headquartered in Rockville, MD. | Commercial Services |